En Es
Categories

Industry News


Siemens Healthineers’ AI-Based Chest CT Software Receives US FDA Clearance

By Medimaging International staff writers
15 Oct 2019

Image: The AI-Rad Companion Chest CT automatically generates standardized, reproducible, and quantitative reports in DICOM SC format (Photo courtesy of Siemens Healthineers).The US Food and Drug Administration (FDA) has cleared three modules of AI-Rad Companion Chest CT, an intelligent software assistant from Siemens Healthineers (Erlangen, Germany) that brings artificial intelligence (AI) to computed tomography (CT). Representing the first intelligent assistant of the new AI-Rad Companion platform, AI-Rad Companion Chest CT helps radiologists interpret images of the thorax (chest) quickly with desired accuracy and precision, and automatically documents these findings as structured reports.

The algorithms in AI-Rad Companion Chest CT have been trained on extensive datasets and annotated by qualified clinical specialists to provide segmentation, measurement, and highlighting of key anatomical structures, to support quantitative and qualitative analysis. Using CT images of the chest, AI-Rad Companion Chest CT differentiates among various structures in that region, including the lungs, heart, and aorta, highlights them individually, and marks and measures potential abnormalities, such as coronary calcifications.

It supports a variety of tasks, including automated detection of lesions, localization of abnormalities, and measurement of lung lesions; quantification of per-lobe low-attenuation parenchyma; enhanced visualization of lung lesions; automated segmentation of lung lobes and enhanced visualization of low-attenuation parenchyma; segmentation and measurement of maximum diameters of the thoracic aorta; quantification of the total calcium volume in the coronary arteries; and detection of nine anatomical landmarks as identified by American Heart Association (AHA) guidelines.

Based on the AI-supported analysis, AI-Rad Companion Chest CT automatically generates standardized, reproducible, and quantitative reports in Digital Imaging and Communications in Medicine (DICOM) SC format. In addition to reducing time spent on manual results documentation, these reports can be accessed by radiologists on the picture archiving and communication system (PACS) in the clinical routine. AI-Rad Companion Chest CT also highlights potentially clinically relevant changes that might otherwise remain unnoticed because they were not the primary indication for the exam.

“AI-Rad Companion Chest CT builds on our decades-long expertise in AI and machine learning, digitalizing healthcare and helping providers perform multi-organ image interpretation of the chest with enhanced detection, accuracy, and precision, which can potentially improve outcomes,” said David Pacitti, President and Head of the Americas at Siemens Healthineers.



E-mail Print
FaceBook Twitter Google+ Linked in

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for the medical industry
Gold member
More info

More articles about Siemens Healthineers

13 Aug 2019
Siemens Healthineers' Acquires Corindus to Enhance Robotic-Assisted Interventions
Siemens Healthineers AG has entered into a merger agreement with Corindus Vascular Robotics, Inc. to acquire the company, which offers a robotic treatment platform for the major vascular therapeutic markets, including coronary, peripheral vascular and neurovascular interventions.
Read More
05 Aug 2019
Siemens Healthineers Receives Recognition AI Applications in Radiology
Based on its recent analysis of the global precision imaging market, Frost & Sullivan, a growth strategy consulting and research firm, has recognized Siemens Healthineers with the 2019 Global Visionary Innovation Leadership Award for leading the effort to establish imaging as an active contributor to precision medicine.
Read More
07 Feb 2019
Global MRI Systems Market to Grow by USD 1.5 Billion in 2019-2023
The global MRI systems market size is projected to grow at a CAGR of more than 5%, or by almost USD 1.58 billion, during the forecast period 2019-2023, driven primarily by technological advances.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
06 Jun 2018
Siemens Healthineers and ScreenPoint Medical to Develop AI-Based Apps
Siemens Healthineers and ScreenPoint Medical have entered into a partnership to develop artificial intelligence (AI)-based applications for breast imaging. As part of the arrangement, Siemens Healthineers will also acquire a strategic minority stake in ScreenPoint Medical.
Read More
26 Apr 2018
Siemens Healthineers Launches Thermocycler with AI-Powered Software
Siemens Healthineers launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation.
Read More
27 Feb 2018
Siemens Healthineers AG IPO Planned for First Half of 2018
Global technology powerhouse Siemens AG and its separately managed healthcare business, Siemens Healthineers have announce that the planned IPO of Siemens Healthineers AG is expected to be completed in the first half of calendar year 2018, subject to capital market conditions.
Read More
18 Jan 2018
Siemens Healthineers Strategy 2025 to Focus on AI
Siemens Healthineers has laid out its strategy to bolster its market leadership by 2025 and beyond, aimed at accelerating profitable growth and delivering return. The company has stated that it is well prepared to take advantage of the paradigm shift and structural growth opportunities in healthcare.
Read More

Additional news

23 Mar 2020
Artificial Intelligence-Based Methods to Cut MRI Read Times Receives USD 250K Grant
 Research to detect and predict blocked arteries and cardiovascular risk using knee MRI images conducted by Chun Yuan, Ph.D., Professor of Radiology and Bioengineering and Vice Chair for Global Affairs at the University of Washington (Seattle, WA, USA) has been recognized and awarded a grant by the American Heart Association’s (AHA) Institute for Precision Cardiovascular Medicine (Dallas, TX, USA).
Read More
23 Mar 2020
Surgical Robots Market to Reach USD 13.1 Billion by 2027 Due to High Acceptance in Emerging Regions
 The global surgical robots market is forecasted to reach USD 13.1 billion by 2027, driven mainly by low turn-around times and increased innovation in robotics over the coming years. Surgical robots are finding increased acceptance in the emerging Asia region, according to a study by Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider. The study is based on recent findings by IEEE (an Association for Electronic Engineering) that millennial parents are increasingly opting for robotic surgeries for their children in Asia Pacific region. The study also reveals that low availability of robotic surgeries remains a concern.
Read More
19 Mar 2020
Advantech Launches Medical-Grade AVAS-400 Series 4K UHD Video Recorder
 Advantech Co., Ltd. (Taipei, Taiwan), a provider of medical computing platforms and solutions, has launched its AVAS-400 Series medical-grade 4K ultra high-definition (UHD) video recorder aimed at ensuring operating precision. Advantech’s AVAS-400 Series, which includes two models, the AVAS-401 and the AVAS-402, are ideal for surgery centers, operating rooms, and training facilities that use 4K UHD cameras and display monitors for surgical operations and post-surgery reviews and research.
Read More
19 Mar 2020
Artificial Intelligence Helps Cancer Patients Start Radiation Therapy Sooner
 A new study by researchers from UT Southwestern’s Medical Artificial Intelligence and Automation (MAIA) Lab (Dallas, TX, USA) has demonstrated that artificial intelligence (AI) can help cancer patients start their radiation therapy sooner – and thereby decrease the odds of the cancer spreading – by instantly translating complex clinical data into an optimal plan of attack.
Read More
18 Mar 2020
Global Radiation Therapy Market to Reach USD 8.6 Billion by 2026 on Back of Product Approvals
 The global radiation therapy market is projected to record a steady growth rate of 5.2% from 2018 to 2026 to reach USD 8.6 billion by 2026, driven by a surge in product approvals, increased expenditure on healthcare, high incidence of cancer, growing preference for non-invasive treatment procedures, technological advancements, and notable research and development activities.
Read More
18 Mar 2020
Global Multiparameter Patient Monitoring Devices Market to Reach USD 6 Billion by 2025
 The global multiparameter patient monitoring devices market is expected to grow at a CAGR of over 4%, or record an incremental growth of around USD 1.32 billion, during the forecast period 2019?2025 to reach USD 6 billion in 2025. These are the latest findings of Arizton (Chicago, IL, USA), a provider of market research solutions.
Read More
17 Mar 2020
AI-based Ultrasound Echo Imaging Software Receives FDA Marketing Authorization
 The US Food and Drug Administration (FDA) has authorized the marketing of a software that uses artificial intelligence (AI) to assist medical professionals in the acquisition of cardiac ultrasound images. The software, Caption Guidance from Caption Health (Brisbane, CA, USA), a medical AI company, uses AI to empower medical professionals without specialized training to perform cardiac ultrasound.
Read More
17 Mar 2020
Global Defibrillators Market Projected to Reach USD 11.7 Billion by 2025
 The global defibrillators market is projected to grow at a CAGR of 3.4% from USD 9.6 billion in 2019 to USD 11.7 billion by 2025, driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. Additionally, the emerging markets and the development of S-ICDs and MRI-compatible ICDs and CRT-Ds are expected to offer growth opportunities for the players in the defibrillators market. However, issues related to the use of implantable and automated external defibrillators, frequent product recalls, and lack of awareness about sudden cardiac arrest in the developing countries are expected to hinder the growth of the market during the forecast period.
Read More
16 Mar 2020
Global Blood Glucose Monitoring Devices Market to Reach USD 13 Billion by 2023
 The global blood glucose monitoring devices (BGMDs) market was valued at nearly USD 8 billion in 2018 and is projected to grow at a fast-paced CAGR of approximately 11% to reach USD 13 billion by 2023, driven by the phenomenal sales growth of new revolutionary continuous glucose monitoring systems (CGMs). However, the growth of CGMs will be offset by a steady decline in the blood glucose meters (BGMs) segment due to continued extreme price competition/downward pricing pressure, lowered test-strip reimbursement, and market saturation of lower-cost meters, among other factors.
Read More
Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions